thiosulfates has been researched along with Diabetes Mellitus, Type 2 in 10 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Calciphylaxis is associated with medial arteriolar vascular calcification and results in ischemic subcutaneous necrosis with vulnerable skin ulcerations and high mortality." | 6.43 | Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. ( Hayden, MR; Khanna, R; Kolb, L; Sowers, JR; Tyagi, SC, 2005) |
| "Calciphylaxis is associated with medial arteriolar vascular calcification and results in ischemic subcutaneous necrosis with vulnerable skin ulcerations and high mortality." | 2.43 | Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. ( Hayden, MR; Khanna, R; Kolb, L; Sowers, JR; Tyagi, SC, 2005) |
| "Calciphylaxis is a very uncommon and severe disease which mainly appears in patients with chronic renal insufficiency." | 2.43 | Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? ( Gille, J; Kaufmann, R; Meissner, M, 2006) |
| "Calciphylaxis is a serious condition that often occurs in patients with end-stage renal failure undergoing hemodialysis, with potential comorbidities of hyperparathyroidism and chronic kidney disease (CKD)." | 1.56 | Calciphylaxis in Stage 3 Chronic Kidney Disease on Apixaban Successfully Treated With Sodium Thiosulfate: A Case Report. ( Ali, F; Friedman, BJ; Gordon Spratt, E; Matharu, T; Nagesh, RV, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dahmani, ZM | 1 |
| Li, X | 1 |
| Wiggenhauser, LM | 1 |
| Ott, H | 1 |
| Kruithof, PD | 1 |
| Lunev, S | 1 |
| A Batista, F | 1 |
| Luo, Y | 1 |
| Dolga, AM | 1 |
| Morton, NM | 1 |
| Groves, MR | 1 |
| Kroll, J | 1 |
| van Goor, H | 1 |
| Ali, F | 1 |
| Matharu, T | 1 |
| Nagesh, RV | 1 |
| Gordon Spratt, E | 1 |
| Friedman, BJ | 1 |
| Fiel, DC | 1 |
| Margarido Malvar, HB | 1 |
| Dias Silva, RA | 1 |
| Devey, S | 1 |
| Valois, A | 1 |
| Cazajous, G | 1 |
| Beaume, J | 1 |
| Abed, S | 1 |
| Okhremchuk, I | 1 |
| Spadoni, S | 1 |
| Boyé, T | 1 |
| Morand, JJ | 1 |
| Garcia, CP | 1 |
| Roson, E | 1 |
| Peon, G | 1 |
| Abalde, MT | 1 |
| De La Torre, C | 1 |
| Brucculeri, M | 1 |
| Rullan, E | 1 |
| Zanchi, A | 1 |
| Marcotte, A | 1 |
| Van Noten, C | 1 |
| Janssen van Doorn, K | 1 |
| Vermander, E | 1 |
| Vlayen, S | 1 |
| Verpooten, GA | 1 |
| Couttenye, MM | 1 |
| Hayden, MR | 1 |
| Tyagi, SC | 1 |
| Kolb, L | 1 |
| Sowers, JR | 1 |
| Khanna, R | 1 |
| Meissner, M | 1 |
| Gille, J | 1 |
| Kaufmann, R | 1 |
| Köstler, E | 1 |
| Wollina, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| European Calciphylaxis Registry Network[NCT02635373] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2015-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for thiosulfates and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.
Topics: Animals; Antioxidants; Arteries; Atherosclerosis; Calcinosis; Calciphylaxis; Chelating Agents; Chron | 2005 |
Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbar | 2006 |
8 other studies available for thiosulfates and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Hyperglycemia; Models, Theoretical; Pronephros; Thiosulfate Sulf | 2022 |
Calciphylaxis in Stage 3 Chronic Kidney Disease on Apixaban Successfully Treated With Sodium Thiosulfate: A Case Report.
Topics: Aged; Antioxidants; Calciphylaxis; Diabetes Mellitus, Type 2; Factor Xa Inhibitors; Female; Humans; | 2020 |
The role of mammography in calcific uremic arteriolopathy.
Topics: Aged; Arterioles; Biopsy; Calcinosis; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies | 2017 |
[Calciphylaxis in hemodialysis patients: 8 cases treated with sodium thiosulfate].
Topics: Aged; Aged, 80 and over; Calciphylaxis; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabet | 2018 |
Calciphylaxis treated with sodium thiosulfate: report of two cases.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Atrial Fibrillation; Calciphylaxis; Comorbidity; Diabetes Me | 2013 |
Role of sodium thiosulfate therapy in the treatment of digital necrosis due to Mönckeberg sclerosis.
Topics: Diabetes Mellitus, Type 2; Fingers; Gangrene; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mo | 2014 |
Maximal conservative therapy of calcific uremic ateriolopathy.
Topics: Arterioles; Calcimimetic Agents; Chelating Agents; Cinacalcet; Combined Modality Therapy; Diabetes M | 2012 |
[Reader's letter on Marcus Meissner, Jens, Gille, Roland Kaufmann. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?].
Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbar | 2007 |